Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by floatinketuckyon Mar 03, 2022 2:48pm

588 Views

Post# 34480226

What is the market eval for NMIBC NONRESPONSE. .37 to 6.00$

SESN was racing to the lead for NMIBC NONRESPONSE.

But they had to mamy violations and not good results.

but before they blew out and had to get off the racetrack
to the NMIBC NONRESPONSE Checkered flag.

SESN ran from .37 cents to over sex bucks a share!

Who is the FDA darling With a 2b piv-vital?

BTD AA in progress!!

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market